Grace Taylor, MS, MA

News
A Deep Learning Model for Predicting Immune Checkpoint Inhibitor Efficacy in NSCLC
01/08/2025
Researchers developed and validated a deep learning model, Deep-IO, designed to predict the efficacy of immune checkpoint inhibitors (ICIs) in treating advanced non-small cell lung cancer (NSCLC), according to a study published in JAMA...
Researchers developed and validated a deep learning model, Deep-IO, designed to predict the efficacy of immune checkpoint inhibitors (ICIs) in treating advanced non-small cell lung cancer (NSCLC), according to a study published in JAMA...
Researchers developed and...
01/08/2025
Journal of Clinical Pathways
News
COVID-19 Infection Linked to Increased Risk of Skin Conditions
01/08/2025
A recent study found that COVID-19 infection significantly increases the risk of developing skin conditions such as vitiligo, chronic urticaria, alopecia areata, and herpes zoster.
A recent study found that COVID-19 infection significantly increases the risk of developing skin conditions such as vitiligo, chronic urticaria, alopecia areata, and herpes zoster.
A recent study found that...
01/08/2025
First Report Managed Care
Conference Coverage
Impact of Clinical Pharmacist-Led Non-Oncology Infusion Management
12/11/2024
A study presented at the 2024 ASHP Midyear Clinical Meeting evaluated the impact of a pharmacist-led non-oncology infusion therapy management protocol, showing improvements in operational efficiency and other areas.
A study presented at the 2024 ASHP Midyear Clinical Meeting evaluated the impact of a pharmacist-led non-oncology infusion therapy management protocol, showing improvements in operational efficiency and other areas.
A study presented at the 2024...
12/11/2024
Pharmacy Learning Network
Conference Coverage
Impact of Prior Authorization Removal on SGLT2 Inhibitor Utilization
12/10/2024
At the 2024 ASHP Midyear Clinical Meeting, researchers presented on the impact of removing prior authorization (PA) restrictions on the utilization of sodium-glucose co-transporter-2 inhibitors (SGLT2i) in a primary care safety net clinic...
At the 2024 ASHP Midyear Clinical Meeting, researchers presented on the impact of removing prior authorization (PA) restrictions on the utilization of sodium-glucose co-transporter-2 inhibitors (SGLT2i) in a primary care safety net clinic...
At the 2024 ASHP Midyear...
12/10/2024
Pharmacy Learning Network
AI
News
The Potential for AI in Oncology
04/11/2024
Jim Chen, MD, and Sanjay Doddamani, MD, MBA, provide an overview of where artificial intelligence technology stands today and how it comes into play within the oncology space.
Jim Chen, MD, and Sanjay Doddamani, MD, MBA, provide an overview of where artificial intelligence technology stands today and how it comes into play within the oncology space.
Jim Chen, MD, and Sanjay...
04/11/2024
Journal of Clinical Pathways
News
Evaluation of First-Line Treatment Outcomes in Elderly Patients with Diffuse Large B-Cell Lymphoma
12/04/2023
Steven Bair, MD, and colleagues evaluated long-term outcomes across different first-line treatment regimens for elderly patients with DLBCL, including standard dose R-CHOP, reduced dose R-CHOP, and non-anthracycline alternative regimens.
Steven Bair, MD, and colleagues evaluated long-term outcomes across different first-line treatment regimens for elderly patients with DLBCL, including standard dose R-CHOP, reduced dose R-CHOP, and non-anthracycline alternative regimens.
Steven Bair, MD, and colleagues...
12/04/2023
Journal of Clinical Pathways
Conference Coverage
Case Studies of New Patient Access Programs at Two Cancer Centers
04/27/2023
Kimberly Bell, RN, MBA, Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic, and Danielle McLaughlin, MPH, University of California San Diego, Moores Cancer Center, highlight different strategies...
Kimberly Bell, RN, MBA, Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic, and Danielle McLaughlin, MPH, University of California San Diego, Moores Cancer Center, highlight different strategies...
Kimberly Bell, RN, MBA, Case...
04/27/2023
Journal of Clinical Pathways
News
Study Analyzes Trends in Medicare Spending on Oral Drugs for Chronic Lymphocytic Leukemia From 2014 to 2020
05/11/2023
Edward R. Scheffer Cliff, MBBS, MPH, Program on Regulation, Therapeutics and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA, and colleagues recently evaluated...
Edward R. Scheffer Cliff, MBBS, MPH, Program on Regulation, Therapeutics and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA, and colleagues recently evaluated...
Edward R. Scheffer Cliff, MBBS,...
05/11/2023
Journal of Clinical Pathways
News
HAVEN 7 Trial Evaluates Emicizumab Prophylaxis in Infants With Hemophilia A
06/19/2024
A study evaluated the efficacy, safety, pharmacokinetics, and pharmacodynamics of emicizumab in infants from birth to age ≤12 months who have hemophilia A without factor VIII inhibitors.
A study evaluated the efficacy, safety, pharmacokinetics, and pharmacodynamics of emicizumab in infants from birth to age ≤12 months who have hemophilia A without factor VIII inhibitors.
A study evaluated the efficacy,...
06/19/2024
First Report Managed Care
News
Cost-Effectiveness of Lisocabtagene Maraleucel vs Axicabtagene Ciloleucel and Tisagenlecleucel for Third-Line or Later Treatment for R/R DLBCL
11/06/2023
Researchers compared the cost of treatment for different chimeric antigen receptor T-cell therapies as third-line or later treatment for patients with relapsed or refractory large B-cell lymphoma in the US.
Researchers compared the cost of treatment for different chimeric antigen receptor T-cell therapies as third-line or later treatment for patients with relapsed or refractory large B-cell lymphoma in the US.
Researchers compared the cost of...
11/06/2023
Pharmacy Learning Network

Upcoming Events

February 2 ⁠–⁠ February 5
LLM Winter Symposium
February 7 ⁠–⁠ February 9
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
GD Solid Tumors
March 22 ⁠–⁠ March 23
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 4
WoundCon
May 1 ⁠–⁠ May 3
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use